Pictor Limited - Latest News [Page 1]

Pictor Receives CE Mark For PictArray™ SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster

Thursday, 23 June 2022, 6:44 am | Pictor Limited

Following a recent funding round raising $8.8 million, Auckland biotech company Pictor today announced it has received confirmation of CE registration for its PictArray™ SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test as per In ... More >>

Biotech Firm Tackling COVID-19 & M. Bovis Announces Successful Development Of Rapid, Accurate Johne’s Disease Assay

Monday, 13 June 2022, 8:18 pm | Pictor Limited

Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) – also known as Johne’s disease – that could save the New Zealand dairy industry ... More >>

Bolstered By Investment, Pictor Partners With Mobility Health To Offer PictArray™ Antibody Test

Thursday, 14 April 2022, 10:05 am | Pictor Limited

LOS ANGELES, California, USA — April 13, 2022 — Following a new investment of $6.1 million (NZD $8.8 million), biotech company Pictor today announced a partnership with U.S. laboratory service provider Mobility Health , launching a new antibody ... More >>

Pictor's Completes Successful US Clinical Trials For Unique COVID Antibody Testing

Tuesday, 11 January 2022, 6:12 pm | Pictor Limited

New Zealand diagnostic biotech company Pictor’s world-leading COVID-19 antibody testing regime has completed validation trials at two separate sites the United States. The Pictor test simultaneously detects the presence of both anti-Spike Antigen (SP) ... More >>

Pictor Ltd. Announces Start Of US Clinical Trials For SARS-CoV-2 Serology Test

Wednesday, 27 October 2021, 7:54 am | Pictor Limited

Auckland-based diagnostic biotech company Pictor has taken a major step forward in the development of its COVID-19 antibody test, announcing it has signed two US laboratories to conduct clinical trials in the US. Earlier this year, Pictor announced ... More >>

Pictor Ready To Roll Out Game-changing COVID Antibody Test In New Zealand

Thursday, 21 October 2021, 11:55 am | Pictor Limited

World-leading COVID-19 antibody test developed by Auckland diagnostic biotech company Pictor will be available for use in New Zealand before the end of November, the company has announced. The test could make New Zealand’s long-awaited easing of border ... More >>

Pictor And SCIENION Partner To Commercialise High-throughput SARS-CoV-2 Antibody Testing System

Wednesday, 29 September 2021, 10:24 am | Pictor Limited

Auckland-based diagnostic biotech company Pictor has entered into a strategic collaboration with SCIENION, a BICO company, to commercialise a high throughput SARS-CoV-2 antibody testing system. The two companies will incorporate SCIENION’s CL2 sciREADER system ... More >>

IVD medical expert joins Pictor leadership team

Thursday, 2 September 2021, 10:10 am | Pictor Limited

Auckland-based biotechnology company Pictor Limited has named US-based Tadd S. Lazarus, M.D. as its Consulting Chief Medical Officer. Dr Lazarus, who is based in San Diego, California and Austin, Texas, brings extensive experience as a Medical Director and ... More >>

Fast disease testing just a pinprick away

Friday, 29 May 2009, 10:21 am | Pictor Limited

A biotechnology company that started life in an Auckland garage has signed deals with partners in India and Europe, just four years after its founders began developing unique technology that can screen for a range of diseases from just a drop of blood. More >>